Belgian Body Welcomes Clawback Exemption For Generics/Biosimilars Amid Price Cuts

 
• By Dave Wallace

Belgian body Medaxes is content with the latest pharmaceutical pricing legislation in the country, which cuts generics and biosimilars prices but also exempts such drugs from pharmaceutical clawback taxes.

Belgium
The latest Belgian legislation has cut prices • Source: Shutterstock

More from Pricing Debate

More from Market Access